13 results match your criteria qEASL

  • Page 1 of 1

Quantitative imaging biomarkers for Yttrium-90 distribution on Bremsstrahlung single photon emission computed tomography after resin-based radioembolization.

J Nucl Med 2019 Jan 17. Epub 2019 Jan 17.

Charite University, Yale University School of Medicine, United States.

To identify baseline imaging features in patients with liver cancer that correlate with Yttrium-90 (Y) distribution on post-procedural single photon emission computed tomography (SPECT) and predict tumor response to transarterial radioembolization (TARE). This retrospective study was approved by the institutional review board and included 38 patients with hepatocellular carcinoma (HCC) ( = 23, 18/23 males, mean age 62.39±8. Read More

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.118.219
Publisher Site
http://dx.doi.org/10.2967/jnumed.118.219691DOI Listing
January 2019
8 Reads

Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.

J Vasc Interv Radiol 2018 06 14;29(6):850-857.e1. Epub 2018 Mar 14.

Department of Radiology and Biomedical Imaging, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520. Electronic address:

Purpose: To use magnetic resonance (MR) imaging and clinical patient data to create an artificial intelligence (AI) framework for the prediction of therapeutic outcomes of transarterial chemoembolization by applying machine learning (ML) techniques.

Materials And Methods: This study included 36 patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization. The cohort (age 62 ± 8. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2018.01.769DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970021PMC
June 2018
33 Reads

Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

Cardiovasc Intervent Radiol 2018 Mar 30;41(3):433-442. Epub 2017 Oct 30.

Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.

Purpose: Our study aimed to evaluate quantitative tumor response assessment (quantitative EASL-[qEASL]) on computed tomography (CT) images in patients with hepatocellular carcinoma (HCC) treated using conventional transarterial chemoembolization (cTACE), compared to existing 1-dimensional and 2-dimensional methods (RECIST, mRECIST, EASL).

Materials And Methods: In this IRB-approved, single-institution retrospective cohort study, 52 consecutive patients with intermediate-stage HCC were consecutively included. All patients underwent contrast-enhanced CT scan at baseline and 4 weeks after cTACE. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-017-1829-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803331PMC
March 2018
77 Reads

The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.

Clin Imaging 2017 Nov - Dec;46:1-7. Epub 2017 Jun 7.

Yale School of Medicine, Department of Radiology and Biomedical Imaging, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address:

Purpose: To investigate whether bevacizumab compromises early response assessment after Transarterial Chemoembolization (TACE) in patients with hepatocellular carcinoma by 3D quantitative European Association for the Study of the Liver (qEASL) criteria in comparison to other imaging-based criteria.

Materials And Methods: Each of 14 patients receiving TACE and bevacizumab was matched with two patients receiving TACE alone. Baseline and Follow-up MRI was retrospectively analyzed regarding qEASL and other imaging-based criteria. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2017.05.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720941PMC
May 2018
27 Reads

Intra-arterial therapies for liver cancer: assessing tumor response.

Expert Rev Anticancer Ther 2017 Feb 27;17(2):119-127. Epub 2016 Dec 27.

b Department of Radiology and Biomedical Imaging , Yale School of Medicine , New Haven , CT , USA.

Introduction: Intra-arterial therapies (IATs) play an integral role in the management of unresectable hepatocellular carcinoma and liver metastases. The ability to accurately assess tumor response to intra-arterial therapies is crucial for clinical management. Several one- and two-dimensional manual imaging-based response assessment techniques, based both on tumor size or enhancement, have shown to be highly subjective and merely surrogate for the actual tumor as a whole. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1273775DOI Listing
February 2017
15 Reads

Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis.

Transl Oncol 2016 Oct 12;9(5):377-383. Epub 2016 Sep 12.

Yale University School of Medicine, Yale New Haven Hospital, New Haven, CT, USA. Electronic address:

Purpose: Liver metastases from renal cell carcinoma (RCC) are not uncommon in the course of disease. However, data about tumor response to intraarterial therapy (IAT) are scarce. This study assessed whether changes of enhancing tumor volume using quantitative European Association for the Study of the Liver (qEASL) on magnetic resonance imaging (MRI) and computed tomography (CT) can evaluate tumor response and predict overall survival (OS) early after therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2016.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021812PMC
October 2016
29 Reads

Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.

Radiology 2016 Jan 1;278(1):275-84. Epub 2015 Jul 1.

From the Russell H. Morgan Department of Radiology and Radiological Science, Division of Vascular and Interventional Radiology (V.T., R.D., H.Y., H.L., J.C., M.C., Z.W., J.H.S., J.F.G.), and Department of Surgery (T.P.), Johns Hopkins Hospital, 1800 Orleans St, Baltimore, MD 21287; Department of U/S Imaging and Interventions, Philips Research North America, Briarcliff Manor, NY (M.L.); Department of Biostatistics, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Md (C.F.); and The Rothman Institute, Philadelphia, Pa (M.G.M.).

Purpose: To compare currently available non-three-dimensional methods (Response Evaluation Criteria in Solid Tumors [RECIST], European Association for Study of the Liver [EASL], modified RECIST [mRECIST[) with three-dimensional (3D) quantitative methods of the index tumor as early response markers in predicting patient survival after initial transcatheter arterial chemoembolization (TACE).

Materials And Methods: This was a retrospective single-institution HIPAA-compliant and institutional review board-approved study. From November 2001 to November 2008, 491 consecutive patients underwent intraarterial therapy for liver cancer with either conventional TACE or TACE with drug-eluting beads. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015142951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695977PMC
January 2016
17 Reads

Radiologic-pathologic analysis of quantitative 3D tumour enhancement on contrast-enhanced MR imaging: a study of ROI placement.

Eur Radiol 2016 Jan 21;26(1):103-13. Epub 2015 May 21.

U/S Imaging and Interventions (UII), Philips Research North America, Briarcliff Manor, NY, USA.

Objectives: To investigate the influence of region-of-interest (ROI) placement on 3D tumour enhancement [Quantitative European Association for the Study of the Liver (qEASL)] in hepatocellular carcinoma (HCC) patients treated with transcatheter arterial chemoembolization (TACE).

Methods: Phase 1: 40 HCC patients had nine ROIs placed by one reader using systematic techniques (3 ipsilateral to the lesion, 3 contralateral to the lesion, and 3 dispersed throughout the liver) and qEASL variance was measured. Intra-class correlations were computed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-015-3812-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654989PMC
January 2016
16 Reads

Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.

Eur Radiol 2015 Jul 31;25(7):1993-2003. Epub 2015 Jan 31.

Russell H. Morgan Department of Radiology and Radiological Science, Division of Vascular and Interventional Radiology, The Johns Hopkins Hospital, Sheikh Zayed Tower, Ste 7203, 1800 Orleans St, Baltimore, MD, 21287, USA.

Objectives: This study evaluated the predictive role of 1D, 2D and 3D quantitative, enhancement-based MRI regarding overall survival (OS) in patients with colorectal liver metastases (CLM) following intra-arterial therapies (IAT).

Methods: This retrospective analysis included 29 patients who underwent transarterial chemoembolization (TACE) or radioembolization and received MRI within 6 weeks after therapy. Tumour response was assessed using 1D and 2D criteria (such as European Association for the Study of the Liver guidelines [EASL] and modified Response Evaluation Criteria in Solid Tumors [mRECIST]). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-015-3595-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458393PMC
July 2015
17 Reads

Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival.

Eur J Radiol 2015 Mar 13;84(3):424-430. Epub 2014 Dec 13.

Russell H. Morgan Department of Radiology and Radiological Science, Division of Vascular and Interventional Radiology, The Johns Hopkins Hospital, Sheikh Zayed Tower, Suite 7203, 1800 Orleans St, Baltimore, MD, USA 21287. Electronic address:

Background: The clinical management of patients with metastatic soft-tissue sarcoma of the liver is complicated by the paucity of reliable clinical data. This study evaluated the safety profile, survival outcome as well as the role of imaging biomarkers of tumor response in metastatic soft-tissue sarcoma (mSTS) of the liver treated with conventional transarterial chemoembolization (cTACE).

Materials/methods: This retrospective analysis included 30 patients with mSTS of the liver treated with cTACE. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2014.11.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315698PMC
March 2015
39 Reads

Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.

Expert Rev Anticancer Ther 2015 Feb 5;15(2):199-205. Epub 2014 Nov 5.

The Russell H. Morgan Department of Radiology and Radiological Sciences, Division of Vascular and Interventional Radiology, The Johns Hopkins Hospital, Johns Hopkins University School of Medicine, 1800 Orleans Street, Sheikh Zayed Tower, Suite 7203, Baltimore, MD 21287, USA.

Assessing the tumor response of liver cancer lesions after intraarterial therapies is of major clinical interest. Over the last two decades, tumor response criteria have come a long way from purely size-based, anatomic methods such as the Response Evaluation Criteria in Solid Tumors towards more functional, enhancement- and diffusion-based parameters with a strong emphasis on MRI as the ultimate imaging modality. However, the relatively low reproducibility of those one- and 2D techniques (modified Response Evaluation Criteria in Solid Tumors and the European Association for the Study of the Liver criteria) provided the rationale for the development of new, 3D quantitative assessment techniques. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.978861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304995PMC
February 2015
5 Reads

Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization.

Transl Oncol 2014 Aug 20;7(4):447-55. Epub 2014 Jun 20.

Russell H. Morgan Department of Radiology and Radiological Science, Division of Vascular and Interventional Radiology, The Johns Hopkins Hospital, Baltimore, MD, 21287, USA. Electronic address:

Purpose: To determine whether volumetric changes of enhancement as seen on contrast-enhanced magnetic resonance (MR) imaging can help assess early tumor response and predict survival in patients with metastatic uveal melanoma after one session of transarterial chemoembolization (TACE).

Materials And Methods: Fifteen patients with 59 lesions who underwent MR imaging before and 3 to 4 weeks after the first TACE were retrospectively included. MR analysis evaluated signal intensities, World Health Organization (WHO), Response Evaluation Criteria in Solid Tumors (RECIST), European Association for the Study of the Liver (EASL), modified RECIST (mRECIST), tumor volume [volumetric RECIST (vRECIST)], and volumetric tumor enhancement [quantitative EASL (qEASL)]. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2014.05.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202794PMC
August 2014
27 Reads

Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.

J Vasc Interv Radiol 2012 Dec;23(12):1629-37

Clinical Informatics, Interventional, and Translational Solutions (CIITS), Philips Research North America, Briarcliff Manor, New York, USA.

Purpose: To show that hepatic tumor volume and enhancement pattern measurements can be obtained in a time-efficient and reproducible manner on a voxel-by-voxel basis to provide a true three-dimensional (3D) volumetric assessment.

Materials And Methods: Magnetic resonance (MR) imaging data obtained from 20 patients recruited for a single-institution prospective study were retrospectively evaluated. All patients had a diagnosis of hepatocellular carcinoma (HCC) and underwent drug-eluting beads (DEB) transcatheter arterial chemoembolization for the first time. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2012.08.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579576PMC
December 2012
40 Reads
  • Page 1 of 1